Financial & competing interests disclosure
AJ Espay is supported by the K23 career development award (NIMH, 1K23MH092735). He has received grant support from CleveMed/Great Lakes Neurotechnologies, Davis Phinney Foundation and Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Solvay, Abbott, Chelsea Therapeutics, TEVA, Impax and Eli Lilly; and honoraria from Novartis, the American Academy of Neurology and the Movement Disorders Society. He serves as assistant editor of Movement Disorders and on the editorial board of The European Neurological Journal and Frontiers in Movement Disorders. A Fasano serves as an editorial board member of Movement Disorders and receives research support from Neureca Onlus, Milan. F Morgante receives research support from Fondazione Neureca Onlus. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.